Ovarian stimulation drugs alter the metabolite content of the growing follicle: in vivo spectroscopic evaluation of follicle fluid


Gungor N. D. , Gungor K.

JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, vol.22, no.2, pp.132-138, 2021 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.4274/jtgga.galenos.2020.2020.0104
  • Journal Name: JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION
  • Journal Indexes: Emerging Sources Citation Index, Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.132-138
  • Keywords: MR spectroscopy, rFSH, aromatase inhibitor, clomiphene citrate, dominant follicle, MAGNETIC-RESONANCE-SPECTROSCOPY, AROMATASE INHIBITORS, CLOMIPHENE CITRATE, OOCYTE MATURATION, PROFILE, WOMEN

Abstract

Objective: To determine and compare metabolite content using magnetic resonance spectroscopy (MRS) of growing follicles in patients with polycystic ovary syndrome (PCOS) receiving recombinant follicle stimulating hormone (rFSH), clomiphene citrate (CC) or aromatase inhibitor (AI) for ovarian stimulation.